GREAT POINT PARTNERS LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
GREAT POINT PARTNERS LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2022$1,433,000
-88.0%
447,820
-85.8%
0.34%
-88.0%
Q2 2022$11,970,000
+2120.8%
3,150,000
+3050.0%
2.87%
+2108.5%
Q1 2022$539,000
-80.4%
100,000
-51.0%
0.13%
-78.8%
Q4 2021$2,755,000
-69.6%
203,900
-59.6%
0.61%
-71.0%
Q3 2021$9,064,000
-76.6%
504,691
-76.2%
2.11%
-40.7%
Q3 2019$38,707,0002,125,0003.56%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2022
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders